Duchenne muscular dystrophy (DMD) is a common genetic disease caused by a mutation of the dystrophin gene. It leads to death in childhood. At the time of writing this paper, patients had access to supportive therapy only. However, DMD treatment methods are actively being developed. Exon skipping is a promising method. Exon skipping involves restoration of the reading frame within a gene by inducing alternative splicing. This leads to synthesis of truncated but still functional dystrophin. The paper assesses the functionality of the truncated forms of dystrophin resulting from correction of nonsense mutations and internal exon indels by exon-skipping technique. The assessment was made based on data on the phenotype of carriers of mutations in the dystrophin gene taken from the Leiden Open Variation Database (LOVD). It was revealed that the same mutation could manifest itself as a variety of phenotypes. This, perhaps, is as a result of the patients having different genetic background. For example, deletion of exon 48, for which there is 97 records in LOVD, resulted in asymptomatic diseases in 2 % of cases, Duchenne muscular dystrophy in 60 %, Becker muscular dystrophy (characterized by milder symptoms than DMD) in 12 % and intermediate phenotype in 26 % of cases. High phenotypic variability of mutations of the dystrophin gene raises the issue of limits of applying exon skipping for treatment of inherited myopathies.
VIEWS 5735
Despite various anti-tuberculosis measures in the setting of HIV infection, the epidemiological situation of tuberculosis in Russia is deteriorating. We have analyzed the data of statistical report form no. 61 for years 2004–2014, surveillance data on individual TB cases with HIV coinfection for years 2004–2014 (personal data) and TB care arrangements for patients with HIV in 20 regions. The main causes of the deteriorating epidemiological situation are the growing immunodeficiency in patients with TB coinfection, unseparated epidemiologically dangerous patient flows (patients with tuberculosis and HIV-infected patients) and low quality preventative measures in special care medical facilities. Chemoprophylaxis can be an effective method of controlling the spread of tuberculosis among HIV-infected patients if it is recommended by a qualified tuberculosis therapist to patients adhering to regular drug intake under supervision of medical personnel. Otherwise a large scale chemoprophylaxis can result in an increased proportion of patients with drug-resistant tuberculosis. This works suggests criteria for the evaluation of tuberculosis care effectiveness considering the pathogenesis of the disease during late stages of HIV.
VIEWS 4566
Brain-computer interfaces (BCIs) are a promising technology intended for the treatment of diseases and trauma of the nervous system. BCIs establish a direct connection between the brain areas that remain functional and assistive devices, such as powered prostheses and orthoses for the arms and legs, motorized wheelchairs, artificial sensory organs and other technologies for restoration of motor and sensory functions. BCIs of various kinds are currently developing very rapidly, aided by the progress in computer science, robotic applications, neurophysiological techniques for recording brain activity and mathematical methods for decoding neural information. BCIs are often classified as motor BCIs (the ones that reproduce movements), sensory BCIs (the ones that evoke sensations), sensorimotor BCIs (the ones that simultaneously handle motor and sensory functions), and cognitive BCIs intended to regulate the higher brain functions. All these BCI classes can be either invasive (i. e. penetrating the body and/or the brain) or noninvasive (i.e. making no o little contact with the body surface). Noninvasive BCI are safe to use and easy to implement, but they suffer from signal attenuation by scalp and skin, its contamination with noise and artifacts, and an overall low information transfer rate. Invasive BCIs are potentially more powerful because they utilize implanted grids that can both record neural signals in high-resolution and apply stimulation to the nervous tissue locally to deliver information back to the brain. BCI technologies are being developed not only for individual use, but also for collective tasks performed by multiple interconnected brains.
VIEWS 5320